Phase
Condition
Post-menopausal Osteopenia
Osteoporosis
Treatment
Romosozumab
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participants diagnosed with osteoporosis who are postmenopausal and have a high riskof fracture who provided inform consent (in-person or through their legallyauthorized representative) to participate in the use of romosozumab per local labelin India.
Exclusion
Exclusion Criteria:
- Participants who experienced myocardial infarction or stroke within a year prior toentering this study.
Study Design
Connect with a study center
Apollo Hospital
New Delhi, Delhi 110076
IndiaSite Not Available
Sir Ganga Ram Hospital
New Delhi, Delhi 110060
IndiaSite Not Available
Stavya Spine Hospital and Research Institute SSHRI
Ahmedabad, Gujarat 380 007
IndiaSite Not Available
MS Ramaiah Medical College and Hospitals
Bangalore, Karnataka 560054
IndiaSite Not Available
King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College
Mumbai, Maharashtra 400012
IndiaSite Not Available
Sancheti Institute for Orthopedics and rehabilitation
Pune, Maharashtra 411005
IndiaSite Not Available
Post Graduate Institute of Medical Education and Research
Chandigarh, Punjab 160 012
IndiaSite Not Available
MGM Healthcare
Chennai, Tamil Nadu 600 029
IndiaSite Not Available
Christain Medical College
Vellore, Tamil Nadu 632004
IndiaSite Not Available
King Georges Medical University
Lucknow, Uttar Pradesh 226 003
IndiaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.